Posts Tagged 'NYSE 2012'

Elan Corp. (NYSE: ELN)

ELN operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. ELN was upgraded by analysts at Deutsche Bank from a “hold” rating to a “buy” rating last week. ELN has a 1 year target price estimate of 14.25.

Snapshot:

• Dec. 16 Close: $11.82
• Day’s Range: 11.57 – 11.94
• Volume: 3,224,220
• Avg. Vol. (3m): 2,617,180
• Market Cap: $6.95B
• EPS (ttm): 1.09
• P/E (ttm): 10.85

ITC Holdings Corp. (NYSE: ITC)

ITC Holdings Corp., through its subsidiaries, engages ...